adagrasib
mirati
['krystal-1', 'sclc', 'mrtx849', 'krystal,1', 'adagrasib', 'nsclc']
the #oncoalerttoptweet day4 #asco22 tweet presents data on adagrasib (mrtx849) in patients with #kras g12c #nsclc and active, untreated cns metastases in krystal-1. about 27-42% have brain metastases - important need. best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??